Concepedia

Yonggui Tian

YT

6

Publications

365

Citations

6

H-Index

2020

Active since

Affiliations

First Affiliated Hospital of Zhengzhou University(Current)

Zhengzhou University

Northwestern University

Henan Cancer Hospital

Yonggui Tian is an author at First Affiliated Hospital of Zhengzhou University specializing in t cell immunity, tumor microenvironment, and autoimmune disease.

Top concepts

Publications per year

2020–2025

6

Publications

6

Metformin Enhances the Antitumor Activity of CD8+ T Lymphocytes via the AMPK–miR-107–Eomes–PD-1 Pathway

Zhen Zhang, Feng Li, Yonggui Tian et al. · The Journal of Immunology · 2020 · 149 citations · Full text

Point mutation in <i>CD19</i> facilitates immune escape of B cell lymphoma from CAR-T cell therapy

Zhen Zhang, Xinfeng Chen, Yonggui Tian et al. · Journal for ImmunoTherapy of Cancer · 2020 · 75 citations · Full text

CXCL9-modified CAR T cells improve immune cell infiltration and antitumor efficacy

Yonggui Tian, Chunli Wen, Zhen Zhang et al. · Cancer Immunology Immunotherapy · 2022 · 47 citations · Full text

, , +9

PD-1 Affects the Immunosuppressive Function of Group 2 Innate Lymphoid Cells in Human Non-Small Cell Lung Cancer

Chunyi Shen, Chaojun Liu, Zhen Zhang et al. · Frontiers in Immunology · 2021 · 41 citations · Full text

Sulforaphane enhances the antitumor response of chimeric antigen receptor T cells by regulating PD-1/PD-L1 pathway

Chunyi Shen, Zhen Zhang, Yonggui Tian et al. · BMC Medicine · 2021 · 32 citations · Full text

Rows per page

1–5 of 6